Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Nicholas Andrew Medland"'
Autor:
Nicholas Andrew Medland, Doug Fraser, Benjamin R. Bavinton, Fengyi Jin, Andrew E. Grulich, Heath Paynter, Rebecca Guy, Hamish McManus
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 1, Pp n/a-n/a (2023)
Abstract Introduction HIV pre‐exposure prophylaxis (PrEP) has been government subsidized in Australia since April 2018 and while uptake is high among men who have sex with men, rates of discontinuation are also high. The aims of this study were to
Externí odkaz:
https://doaj.org/article/9264ed21ca6f408dbfd47097037d50e3
Autor:
NICHOLAS ANDREW MEDLAND
This thesis consists of six individual studies which were conducted at the Melbourne Sexual Health Centre (MSHC) in the three and one half years following that announcement and represent a body of work addressing: how the HIV care cascade is used to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0188dea6f893aa79854f44b7b4be79a3
Autor:
Emilio Bouza, Federico Pulido, Maximo Brito, LUZ MARTÍN CARBONERO, Pablo Okhuysen, Clifford Leen, Vicente Soriano, Giuseppe Tambussi, Vicente Estrada, Juan González-García, Brian Angus, Moreno-Cuerda Victor, Lorenzo Magenta, Sean Emery, Rafael Rubio García, Nicholas Andrew Medland, Philippa Easterbrook, Jose Arribas, Enmoore Lin
Publikováno v:
HIV Medicine. 12:219-227
BACKGROUND AND OBJECTIVES Bacterial pneumonia still contributes to morbidity/mortality in HIV infection despite effective combination antiretroviral therapy (cART). Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)
Autor:
Federico Pulido, Janak Koirala, Carlos Brites, Pablo Okhuysen, DAVID DALMAU, Clifford Leen, Brian Angus, Matti Ristola, Lorenzo Magenta, Lars Østergaard, Sean Emery, Angèle Gayet-Ageron, Michael Kozal, André Cabié, Nicholas Andrew Medland, Philippa Easterbrook
Publikováno v:
University of Helsinki
Mocroft, A, Wyatt, C, Szczech, L, Neuhaus, J, El-Sadr, W, Tracy, R, Kuller, L, Shlipak, M, Angus, B, Klinker, H, Ross, M, INSIGHT SMART Study Group, Østergaard, L J & Nielsen, H I 2009, ' Interruption of antiretroviral therapy is associated with increased plasma cystatin C ', AIDS, vol. 23, no. 1, pp. 71-82 . https://doi.org/10.1097/QAD.0b013e32831cc129
Mocroft, A, Wyatt, C, Szczech, L, Neuhaus, J, El-Sadr, W, Tracy, R, Kuller, L, Shlipak, M, Angus, B, Klinker, H, Ross, M, INSIGHT SMART Study Group, Østergaard, L J & Nielsen, H I 2009, ' Interruption of antiretroviral therapy is associated with increased plasma cystatin C ', AIDS, vol. 23, no. 1, pp. 71-82 . https://doi.org/10.1097/QAD.0b013e32831cc129
Udgivelsesdato: 2009-Jan-2 BACKGROUND: Cystatin C has been proposed as an alternative marker of renal function. We sought to determine whether participants randomized to episodic use of antiretroviral therapy guided by CD4 cell count (drug conservati
Autor:
Fairley Christopher, Michael Kimlin, Peter Ebeling, Mark Boyd, Paul Anderson, Sean Emery, Nicholas Andrew Medland, Karen Klassen
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 27(5)
Summary Rationale: To see if vitamin D and antiretroviraltherapy are associated with bone mineral density (BMD) inpeople with HIV. Result: Lower hipBMD was associated withtenofovir (an antiretroviral medicine) in those with 25(OH)D≥50 nmol/L. Signi
Autor:
Emilio Bouza, Federico Pulido, Esper Kallas, Janak Koirala, Brygida Knysz, LUZ MARTÍN CARBONERO, Ignacio Pérez Valero, Pablo Okhuysen, DAVID DALMAU, Clifford Leen, Vicente Estrada, Juan González-García, Maria Luisa Montes, Moreno-Cuerda Victor, Matti Ristola, Lorenzo Magenta, Lars Østergaard, Aleksandra Szymczak, Sean Emery, Angèle Gayet-Ageron, Michael Kozal, André Cabié, Małgorzata Inglot, Nicholas Andrew Medland, Philippa Easterbrook, Jose Arribas, ANDREA COSTANTINI, Alvaro Humberto Borges, Robert Colebunders
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association, 3(3). Wiley-Blackwell
Nordell, A D, McKenna, M, Borges, Á H, Duprez, D, Neuhaus, J, Neaton, J D & INSIGHT SMART, ESPRIT Study Groups 2014, ' Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation ', Journal of the American Heart Association, vol. 3, no. 3, pp. e000844 . https://doi.org/10.1161/JAHA.114.000844
Nordell, A D, McKenna, M, Borges, Á H, Duprez, D, Neuhaus, J, Neaton, J D, INSIGHT SMART, ESPRIT Study Groups & Andersen, Å B 2014, ' Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation ', Journal of the American Heart Association, vol. 3, no. 3, e000844 . https://doi.org/10.1161/JAHA.114.000844
Dipòsit Digital de la UB
Universidad de Barcelona
Nordell, A D, McKenna, M, Borges, Á H, Duprez, D, Neuhaus, J, Neaton, J D & INSIGHT SMART, ESPRIT Study Groups 2014, ' Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation ', American Heart Association. Journal. Cardiovascular and Cerebrovascular Disease, vol. 3, e000844, pp. 1-10 . https://doi.org/10.1161/JAHA.114.000844
Recercat. Dipósit de la Recerca de Catalunya
instname
Journal of the American Heart Association, 3(3). Wiley-Blackwell
Nordell, A D, McKenna, M, Borges, Á H, Duprez, D, Neuhaus, J, Neaton, J D & INSIGHT SMART, ESPRIT Study Groups 2014, ' Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation ', Journal of the American Heart Association, vol. 3, no. 3, pp. e000844 . https://doi.org/10.1161/JAHA.114.000844
Nordell, A D, McKenna, M, Borges, Á H, Duprez, D, Neuhaus, J, Neaton, J D, INSIGHT SMART, ESPRIT Study Groups & Andersen, Å B 2014, ' Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation ', Journal of the American Heart Association, vol. 3, no. 3, e000844 . https://doi.org/10.1161/JAHA.114.000844
Dipòsit Digital de la UB
Universidad de Barcelona
Nordell, A D, McKenna, M, Borges, Á H, Duprez, D, Neuhaus, J, Neaton, J D & INSIGHT SMART, ESPRIT Study Groups 2014, ' Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation ', American Heart Association. Journal. Cardiovascular and Cerebrovascular Disease, vol. 3, e000844, pp. 1-10 . https://doi.org/10.1161/JAHA.114.000844
Recercat. Dipósit de la Recerca de Catalunya
instname
Background In the general population, raised levels of inflammatory markers are stronger predictors of fatal than nonfatal cardiovascular disease ( CVD ) events. People with HIV have elevated levels of interleukin‐6 ( IL ‐6), high‐sensitivity C
Autor:
Federico Pulido, Janak Koirala, Carlos Brites, Pablo Okhuysen, DAVID DALMAU, Clifford Leen, Ken Kunisaki, TANIA REUTER, Brian Angus, Matti Ristola, Lars Østergaard, Sean Emery, Angèle Gayet-Ageron, Michael Kozal, André Cabié, Sylvie ABEL, Nicholas Andrew Medland, Philippa Easterbrook
Publikováno v:
Bjerk, S M, Baker, J V, Emery, S, Neuhaus, J, Angus, B, Gordin, F M, Pett, S L, Stephan, C, Kunisaki, K M, INSIGHT SMART Study Group & Ristola, M 2013, ' Biomarkers and bacterial pneumonia risk in patients with treated HIV infection : a case-control study ', P L o S One, vol. 8, no. 2, pp. e56249 . https://doi.org/10.1371/journal.pone.0056249
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
PLoS ONE, Vol 8, Iss 2, p e56249 (2013)
PLoS ONE
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
PLoS ONE, Vol 8, Iss 2, p e56249 (2013)
PLoS ONE
Background: Despite advances in HIV treatment, bacterial pneumonia continues to cause considerable morbidity and mortality in patients with HIV infection. Studies of biomarker associations with bacterial pneumonia risk in treated HIV-infected patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2377169135927abf06430f0d991ae784
https://vbn.aau.dk/da/publications/dcc3e440-5441-4a15-91b2-77ba9575dbc5
https://vbn.aau.dk/da/publications/dcc3e440-5441-4a15-91b2-77ba9575dbc5
Autor:
David Gordon, Jennifer Hoy, Michelle Giles, Ian John Woolley, Janaki Amin, Peter Ebeling, Mark Boyd, Jeffrey Post, Sean Emery, Jonathan Anderson, Nicholas Andrew Medland, David Smith
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e38377 (2012)
PLoS ONE
PLoS ONE
Background: Those receiving tenofovir/emtricitabine (TDF-FTC) had greater bone loss compared with abacavir/lamivudine (ABC-3TC) in a randomized simplification trial (STEAL study). Previous studies associated increased bone turnover and bone loss with
Autor:
Federico Pulido, Janak Koirala, Carlos Brites, Jens Lundgren, Pablo Okhuysen, DAVID DALMAU, Clifford Leen, Matti Ristola, Lorenzo Magenta, Sean Emery, Angèle Gayet-Ageron, Michael Kozal, André Cabié, Sylvie ABEL, Martyn French, Nicholas Andrew Medland, Matthew Goetz, Philippa Easterbrook
Publikováno v:
Rodger, A J, Fox, Z, Lundgren, J D, Kuller, L H, Boesecke, C, Gey, D, Skoutelis, A, Goetz, M B, Phillips, A N, [INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group], & Nielsen [INSIGHT (SMART) Study Group], H I 2009, ' Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection ', Journal of Infectious Diseases, vol. 200, no. 6, pp. 973-83 . https://doi.org/10.1086/605447
University of Helsinki
University of Helsinki
Udgivelsesdato: 2009-Sep-15 BACKGROUND: Activation and coagulation biomarkers were measured within the Strategies for Management of Antiretroviral Therapy (SMART) trial. Their associations with opportunistic disease (OD) in human immunodeficiency vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ccab8478a05b10571bc0b8fdaca163b
https://pure.au.dk/portal/da/publications/activation-and-coagulation-biomarkers-are-independent-predictors-of-the-development-of-opportunistic-disease-in-patients-with-hiv-infection(a78189d0-2c29-11df-9806-000ea68e967b).html
https://pure.au.dk/portal/da/publications/activation-and-coagulation-biomarkers-are-independent-predictors-of-the-development-of-opportunistic-disease-in-patients-with-hiv-infection(a78189d0-2c29-11df-9806-000ea68e967b).html
Autor:
Federico Pulido, Graciela Guaragna, Janak Koirala, STEPHEN OBRIEN, Sharon Walmsley, Carlos Brites, Blake McGee, Jens Lundgren, Pablo Okhuysen, DAVID DALMAU, Clifford Leen, George Kinghorn, Giuseppe Tambussi, Matti Ristola, Lorenzo Magenta, Professor Amit Kumar, Lars Østergaard, Sean Emery, Thomas Benfield, Angèle Gayet-Ageron, Alejandro Krolewiecki, Michael Kozal, André Cabié, Sylvie ABEL, Rafael Rubio García, Martyn French, Jonathan Anderson, Nicholas Andrew Medland, Matthew Goetz, Philippa Easterbrook, Barnaby Young, ANASTASIA ANTONIADOU
Publikováno v:
Lundgren, J D, Babiker, A, El-Sadr, W, Emery, S, Grund, B, Neaton, J D, Neuhaus, J, Phillips, A N, Østergaard, L J & Strategies for Management of Antiretroviral Therapy (SMART) Study Group 2008, ' Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up ', Journal of Infectious Diseases, vol. 197, no. 8, pp. 1145-55 . https://doi.org/10.1086/529523
Background and methodsThe SMART study compared 2 strategies for using antiretroviral therapy—drug conservation (DC) and viral suppression (VS)—in 5472 human immunodeficiency virus (HIV)–infected patients with CD4+ cell counts >350 cells/μL. Ra